Cell population growth in chronic myeloid leukaemia

Hodgkin's Disease in 50 Intravenous Drug Users with HIV-Infection.

Leukemia & lymphoma·2016

Induction and Persistence of Complete Remission in a Resistant Acute Myeloid Leukemia Patient after Treatment with Recombinant Interleukin-2.

Leukemia & lymphoma·2016

Short-term administration of granulocyte-macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugs.

Cancer·1993

Has IL2 a role in the management of minimal residual disease for acute leukemia?

Leukemia·1992

Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study.

Leukemia·1992

Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findings.

Leukemia·1992

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Haematologica·2026

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Haematologica·2026

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Haematologica·2026

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Haematologica·2026

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Haematologica·2026

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

Haematologica·2026

Tirofiban-Associated Thrombocytopenia: A Case Report.

Cureus·2026

Body weight rather than unfractionated heparin dose predicts periprocedural bleeding during elective PCI.

International journal of cardiology. Cardiovascular risk and prevention·2026

Adjunctive Cerebrolysin therapy following mechanical thrombectomy for acute basilar artery occlusion: a case report.

Journal of medicine and life·2026

Simultaneous detection of thalassemia, hemoglobinopathies, and G6PD variants using long-read nanopore sequencing: genetic complexity and heterogeneity in Thailand.

PeerJ·2026

First Case Report of Triple Recurrent Cholangitis of "Coildocholithiasis," Following Hepatic Artery Pseudoaneurysm Embolization.

DEN open·2026

Preparative leukapheresis impairs autologous donor hemostasis and platelet function.

Research and practice in thrombosis and haemostasis·2026

Related Experiment Videos

Cell population growth in chronic myeloid leukaemia

Related Concept Videos

Hodgkin's Disease in 50 Intravenous Drug Users with HIV-Infection.

Induction and Persistence of Complete Remission in a Resistant Acute Myeloid Leukemia Patient after Treatment with Recombinant Interleukin-2.

Short-term administration of granulocyte-macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugs.

Has IL2 a role in the management of minimal residual disease for acute leukemia?

Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study.

Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findings.

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

Tirofiban-Associated Thrombocytopenia: A Case Report.

Body weight rather than unfractionated heparin dose predicts periprocedural bleeding during elective PCI.

Adjunctive Cerebrolysin therapy following mechanical thrombectomy for acute basilar artery occlusion: a case report.

Simultaneous detection of thalassemia, hemoglobinopathies, and G6PD variants using long-read nanopore sequencing: genetic complexity and heterogeneity in Thailand.

First Case Report of Triple Recurrent Cholangitis of "Coildocholithiasis," Following Hepatic Artery Pseudoaneurysm Embolization.

Preparative leukapheresis impairs autologous donor hemostasis and platelet function.

Related Experiment Videos

Cell population growth in chronic myeloid leukaemia

Related Concept Videos

Related Articles